Glass House Brands GLAS
NYSE GLAS
$9.52 -0.25 (-2.56%)
At close: Aug 20, 2026 · 4:00 PM EDT

Glass House Brands (GLAS) EBIT Margin Growth (3y) (2024 - 2025)

Glass House Brands (GLAS) EBIT Margin Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 1,129.00
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 2.00
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 59.00
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -1,031.00
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -925.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -46.00
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6,666.00
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Glass House Brands 837.25 Mn 818.69 Mn 15.77 Mn -1,359.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -8,776.00
Sep 30, 2025 544.00
Jun 30, 2025 -8,560.00
Jun 30, 2024 935.00